[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368235-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368235-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","pregnancy-and-the-risk-for-cancer-in-neurofibromatosis-1","Pregnancy and the Risk for Cancer in Neurofibromatosis 1","","Neurofibromatosis type 1 (NF1) confers a high baseline cancer risk, and pregnancy may alter tumor growth, yet whether pregnancy changes cancer risk in NF1 has remained unclear. This study linked pregnancies from a Finnish NF1 cohort and a 10-fold control cohort to national cancer outcomes, summarizing incidence using standardized incidence ratios (SIRs). Findings showed elevated SIRs in NF1 women after pregnancy, while non-NF1 mothers of children with NF1 showed no increase.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/pregnancy-and-the-risk-for-cancer-in-neurofibromatosis-1/368235/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/pregnancy-and-the-risk-for-cancer-in-neurofibromatosis-1/368235.png","ImageObject",300,407,{"name":42,"@type":43},"Aria","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the study question about pregnancy and NF1?","Question",{"text":63,"@type":64},"The study asks whether pregnancy affects the risk for cancer in women with neurofibromatosis type 1 (NF1).","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were cancer outcomes and risk measured?",{"text":68,"@type":64},"Pregnancies in the Finnish NF1 cohort and a 10-fold control cohort were retrieved from the Finnish Medical Birth Register, and cancers during or after pregnancy were obtained from the Finnish Cancer Registry and analyzed using standardized incidence ratios (SIRs).",{"name":70,"@type":61,"acceptedAnswer":71},"What did the results show about cancer risk after pregnancy in NF1 women?",{"text":72,"@type":64},"Cancer incidence after pregnancy was elevated in the NF1 group (e.g., SIRs of 6.44 shortly after pregnancy and 7.54 within 1–10 years), higher than the general population, but similar to NF1 women aged 20–49 overall.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368235,1790387689,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":111,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":117,"preview_page_count":33,"preview_urls":144},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","Genes, Chromosomes and Cancer  \nRESEARCH ARTICLE  OPEN ACCESS   \nPregnancy and the Risk for Cancer in Neurofibromatosis 1  \nRoope A. Kallionpää1,2  | Juha Määttänen1,3,4 | Jussi Leppävirta3,4 | Sirkku Peltonen3,4,5,6,7,8  | Juha Peltonen1,2   \n1Institute of Biomedicine, University of Turku, Turku, Finland | 2FICAN West Cancer Centre, University of Turku and Turku University Hospital, Turku, Finland | 3Department of Dermatology and Venereology, University of Turku, Turku, Finland | 4Department of Dermatology, Turku University Hospital, Turku, Finland | 5Department of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden | 6Department of Dermatology and Venereology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg,  \nSweden | 7Department of Dermatology and Allergology, University of Helsinki, Helsinki, Finland | 8Skin and Allergy Hospital, Helsinki University Hospital, Helsinki, Finland  \nCorrespondence: Juha Peltonen ([juhpel@utu.fi](juhpel@utu.fi))  \nReceived: 24 September 2024 | Revised: 11 December 2024 | Accepted: 13 December 2024  \nFunding: This work was supported by Cancer Foundation Finland, Turku University Hospital, Children's Tumor Foundation, 2023-01-006.  \nKeywords: breast cancer | cancer | neurofibromatosis 1 | NF1 gene | pregnancy  \nABSTRACT  \nBackground: Neurofibromatosis type 1 (NF1) is associated with a high risk for cancer. Benign cutaneous neurofibromas of women with NF1 may increase in size and number during pregnancy. However, it is not known whether pregnancy affects the risk for cancer in NF1 .  \nMethods: We retrieved the pregnancies of women in the Finnish NF1 cohort and in a 10-fold control cohort from the Finnish Medical Birth Register. Cancers occurring during or after pregnancy were obtained from the Finnish Cancer Registry and summarized using standardized incidence ratio (SIR) . The cancer incidence of nonNF1 mothers of individuals with NF1 was also estimated.  \nResults: Totals of 263 pregnancies in 136 women with NF1 and 3176 pregnancies in 1720 controls were observed. In the NF1 group, two cancers were identified during pregnancy and the year following the delivery (SIR 6.44, 95% CI 1.07–19.89). Among controls, the SIR was markedly lower (0.25, 95% CI 0.01–1.08) . Within 1–10 years after pregnancy, the SIR of women with NF1 was 7.54 (95% CI 4.15–12.41). The SIR of women with NF1 aged 20–49 years, and without a known history of deliveries was 8.63 (95% CI 6.08–11.81). The nonNF1 mothers displayed a SIR of 0.81 (95% CI 0.66–1.00) after giving birth to a child with NF1 . Conclusions: The pregnancy-related cancer incidence in women with NF1 is similar to women with NF1 aged 20–49years overall, although notably higher than in the general population. Giving birth to a child with NF1 does not affect the risk for cancer in women without NF1 .  \n1 | Introduction  \nNeurofibromatosis type 1 (NF1; OMIM \\#162200) is a tumor predisposition syndrome caused by pathogenic variants of the NF1 gene that encodes the tumor suppressor protein neurofibromin [1–3] . Our earlier findings indicate that the birth incidence of NF1 can be as high as 1/2000 in the Finnish population [4] . However, due to excess mortality throughout the lifetime, the prevalence of NF1 decreases significantly in older age groups,  \nleading to an average prevalence of 1/4500–1/2000 [5–7] . While the inheritance of NF1 follows a dominant trait, approximately half of the children born with NF1 have no family history of NF1 [5, 6, 8]. NF1 can be reliably diagnosed based on its clinical manifestations [9, 10] .  \nThe hallmark tumors of NF1 include benign cutaneous and plexiform neurofibromas, the latter of which may turn into a malignant peripheral nerve sheath tumor (MPNST) [3, 11, 12] .  \nThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, p","cbCaiu7qe223Lq3G","https://ap.wps.com/l/cbCaiu7qe223Lq3G","pdf",324524,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What is the study question about pregnancy and NF1?\",\"answer\":\"The study asks whether pregnancy affects the risk for cancer in women with neurofibromatosis type 1 (NF1).\"},{\"question\":\"How were cancer outcomes and risk measured?\",\"answer\":\"Pregnancies in the Finnish NF1 cohort and a 10-fold control cohort were retrieved from the Finnish Medical Birth Register, and cancers during or after pregnancy were obtained from the Finnish Cancer Registry and analyzed using standardized incidence ratios (SIRs).\"},{\"question\":\"What did the results show about cancer risk after pregnancy in NF1 women?\",\"answer\":\"Cancer incidence after pregnancy was elevated in the NF1 group (e.g., SIRs of 6.44 shortly after pregnancy and 7.54 within 1–10 years), higher than the general population, but similar to NF1 women aged 20–49 overall.\"}]","Pregnancy and the Risk for Cancer in Neurofibromatosis 1 | PDF",1790175799,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/98cb571a825f6e980d9a440802ba7b03.webp",983,1291,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/112b1ef57a76724830b825326cda3f7c.webp",982,1290,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fb9059876ae83587f05e9f3c57e6e8c9.webp",981,1289,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/48e61dfe457aab0567644a8281ae754e.webp",980,1287]